A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

被引：0
作者：
Alice Maier
Anita Dharan
Gina Oliver
Michael Berk
Suzy Redston
Sudie E. Back
Peter Kalivas
Chee Ng
Richard A. Kanaan
机构：
[1] University of Melbourne,Department of Psychiatry, Austin Health
[2] University of Melbourne,Department of Psychiatry, The Melbourne Clinic
[3] Deakin University,IMPACT – the Institute for Mental and Physical Health and Clinical Translation, School of Medicine
[4] Barwon Health,Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry
[5] The University of Melbourne,Department of Psychiatry and Behavioral Sciences
[6] Austin Health,Department of Neuroscience
[7] Medical University of South Carolina; Ralph H. Johnson VA Medical Center,undefined
[8] Medical University of South Carolina,undefined
[9] Ralph H Johnson VA Medical Center,undefined
来源：
BMC Psychiatry | / 20卷
关键词：
Clinical trial protocol; N-acetyl cysteine; Post-traumatic stress disorder; N-acetyl cysteine; Adjunctive therapy; Randomised clinical trial; Oxidative stress; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Shahin Akhondzadeh
    Raofeh Ghayyoumi
    Farzin Rezaei
    Bahman Salehi
    Amir-Hossein Modabbernia
    Azad Maroufi
    Gholam-Reza Esfandiari
    Mehrangiz Naderi
    Fariba Ghebleh
    Mina Tabrizi
    Shams-Ali Rezazadeh
    Psychopharmacology, 2011, 213 : 809 - 815
  • [42] Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial
    Ebrahimi, Parnia
    Seyedmirzaei, Homa
    Moradi, Kamyar
    Bagheri, Sayna
    Moeini, Mahdi
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (02) : 89 - 95
  • [43] N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
    Yang, Chenghao
    Bosker, Fokko J.
    Li, Jie
    Schoevers, Robert A.
    BMC PSYCHIATRY, 2018, 18
  • [44] N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
    Chenghao Yang
    Fokko J. Bosker
    Jie Li
    Robert A. Schoevers
    BMC Psychiatry, 18
  • [45] Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl
    Tuerk, Peter W.
    Wangelin, Bethany C.
    Powers, Mark B.
    Smits, Jasper A. J.
    Acierno, Ron
    Myers, Ursula S.
    Orr, Scott P.
    Foa, Edna B.
    Hamner, Mark B.
    COGNITIVE BEHAVIOUR THERAPY, 2018, 47 (05) : 351 - 371
  • [46] ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
    S. M. Cotton
    M. Berk
    A. Watson
    S. Wood
    K. Allott
    C. F. Bartholomeusz
    C. C. Bortolasci
    K. Walder
    B. O’Donoghue
    O. M. Dean
    A. Chanen
    G. P. Amminger
    P. D. McGorry
    A. Burnside
    J. Uren
    A. Ratheesh
    S. Dodd
    Trials, 20
  • [47] The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial
    Schulte, M. H. J.
    Goudriaan, A. E.
    Kaag, A. M.
    Kooi, D. P.
    van den Brink, W.
    Wiers, R. W.
    Schmaal, L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (10) : 1377 - 1379
  • [48] Serotonin Reuptake Inhibitor Augmentation with N-Acetylcysteine in Treatment Resistant Obsessive-Compulsive Disorder: A Double-blind Randomized Controlled Trial
    Costa, Daniel L. C.
    Diniz, Juliana B.
    Joaquim, Marines
    Acciarito, Ana C.
    Rodrigues, Bernardo
    Oda, Eduardo F.
    Requena, Guaraci
    Miguel, Euripedes C.
    Pittenger, Christopher
    Bloch, Michael H.
    Shavitt, Roseli G.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 63S - 63S
  • [49] The therapeutic effect of N-acetylcysteine as an add-on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double-blind, placebo-controlled clinical trial
    Padoei, Fateme
    Mamsharifi, Peyman
    Hazegh, Pooya
    Boroumand, Homa
    Ostadmohammady, Fatemeh
    Abbaszadeh-Mashkani, Samira
    Banafshe, Hamid Reza
    Matini, Amir Hassan
    Ghaderi, Amir
    Dehkohneh, Somayeh Ghadami
    BRAIN AND BEHAVIOR, 2023, 13 (01):
  • [50] Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial
    Momtazmanesh, Sara
    Amirimoghaddam-Yazdi, Zeinab
    Moghaddam, Hossein Sanjari
    Mohammadi, Mohammad Reza
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 74 (07) : 398 - 405
12345